Philadelphia Business Journal

Montco Firm Targeting Neurodegenerative Diseases Raises $1.6M

Mitochon Pharmaceuticals said Wednesday it has completed a private stock sale that raised $1.6 million.

Investors in the equity financing included Ben Franklin Technology Partners of Southeastern Pennsylvania.

The proceeds from the financing will be used by the Radnor-based company to advance the development of its lead compound MP101, a neuro-protective agent. The money will also allow Mitochon to further develop a second compound called MP201, being studied as a potential multiple sclerosis therapy.

To read the full article, click here.


For more business news, visit Philadelphia Business Journal. 

Copyright bizjournal
Contact Us